Patent Strategy for Biomedicine Companies-A Case Study on the Amgen Inc. of U.S.A

碩士 === 國立交通大學 === 科技管理所 === 89 === Biotechnology industry is highly knowledge and capital intensive. Not only the technology development takes very long time, the legal disputes display a tough entry barrier for new players. In order to collect enough capital, most new biotechnology companies have t...

Full description

Bibliographic Details
Main Authors: Min-Chu Chu, 朱明珠
Other Authors: Shang-Jyh Liu
Format: Others
Language:zh-TW
Published: 2001
Online Access:http://ndltd.ncl.edu.tw/handle/27679053167094338754